Literature DB >> 24520237

Developmental delay: Need of screening tools for primary care providers.

Syed Sadat Ali1, Syed Ahmed Mustafa2, Pishey Ashwathnarayan Balaji1, Siddaraju Poornima1.   

Abstract

Entities:  

Year:  2013        PMID: 24520237      PMCID: PMC3906778     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


× No keyword cloud information.
Sir, India is committed to reducing childhood mortality and morbidity. This requires advocacy and action (among all stakeholders), focused on locally relevant issues.[1] Developmental delay, “the condition in which a child is not developing and/or achieving skills according to the expected time frame,” is of concern. The barrier to screening for developmental delay is the lack of time in the current practice (82%). Beside the duration of the tests, other reasons for limited use include unfamiliarity, difficulty with their administration, obtaining cooperation of children in a short time, lack of validation in a local setting or language/culture, problems with parental ability to perform self-administered tests and the cost of purchasing some tests.[2] Methods designed specifically for developmental monitoring of young children by health care providers in low- and middle-income (LAMI) countries are lacking.[3] Timely and periodic assessment of young childrens’ development makes it possible to identify and treat developmental disabilities at the earliest possible point of manifestation and to prevent loss of developmental potential.[4] Two tools that are of importance among primary care providers include Ages and Stages questionnaire (ASQ)[56] and Guide for Monitoring Child Development (GMCD).[3] The ASQ is a parent-completed, child development screening test. The ASQ can be used for two purposes: As a first-level screening tool to identify infants and children that may require further assessment As a monitoring tool to gauge the development of children who are at risk for developmental disabilities or delays.[5] The overall sensitivity of ASQ for detecting developmental delay was 83.3% and specificity was 75.4%.[7] A cross-sectional study showed the prevalence of global developmental delay assessed by ASQ to be 19.8%.[8] The GMCD is a practical, open-ended interview that catalyzes communication between clinicians and caregivers. The GMCD is an innovative method for monitoring child development that is designed specifically for use by health care providers in LAMI countries. Studies in Turkey provide preliminary evidence for its reliability and validity.[3] The prevalence of developmental delay assessed by GMCD was found to be 48.5% of children, which shows that a large percentage of children were in need of further follow-up after GMCD assessment.[9] Considering the prevalence of developmental delays, the primary care provider must be vigilant in identifying those children who require further evaluation and referral. Early identification leads to early treatment and, ultimately, improved long-term outcomes.
  4 in total

Review 1.  UNICEF-PHFI Series on newborn and child health, India: methodology for systematic reviews on child health priorities for advocacy and action.

Authors:  Joseph L Mathew; Dheeraj Shah; Tarun Gera; Siddhartha Gogia; Pavitra Mohan; Rajmohan Panda; Subhadra Menon; Piyush Gupta
Journal:  Indian Pediatr       Date:  2011-03       Impact factor: 1.411

2.  Ages and Stages Questionnaire as a screening tool for developmental delay in Indian children.

Authors:  Monica Juneja; Mugdha Mohanty; Rahul Jain; Siddarth Ramji
Journal:  Indian Pediatr       Date:  2011-10-30       Impact factor: 1.411

3.  Assessing development in the pediatric office.

Authors:  Neal Halfon; Michael Regalado; Harvinder Sareen; Moira Inkelas; Colleen H Peck Reuland; Frances P Glascoe; Lynn M Olson
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

4.  A guide for monitoring child development in low- and middle-income countries.

Authors:  Ilgi O Ertem; Derya G Dogan; Canan G Gok; Sevim U Kizilates; Ayliz Caliskan; Gulsum Atay; Nilgun Vatandas; Tugba Karaaslan; Sevgi G Baskan; Domenic V Cicchetti
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.